CLARIANE SE (CLARI.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:CLARI • FR0010386334

3.838 EUR
-0.07 (-1.84%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall CLARI gets a fundamental rating of 3 out of 10. We evaluated CLARI against 29 industry peers in the Health Care Providers & Services industry. CLARI may be in some trouble as it scores bad on both profitability and health. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CLARI has reported negative net income.
  • In the past year CLARI had a positive cash flow from operations.
  • In multiple years CLARI reported negative net income over the last 5 years.
  • Each year in the past 5 years CLARI had a positive operating cash flow.
CLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFCLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of CLARI (-0.43%) is worse than 75.76% of its industry peers.
  • The Return On Equity of CLARI (-1.71%) is worse than 75.76% of its industry peers.
  • CLARI has a Return On Invested Capital of 1.62%. This is amonst the worse of the industry: CLARI underperforms 81.82% of its industry peers.
  • CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 6.49%.
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROIC 1.62%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
CLARI.PA Yearly ROA, ROE, ROICCLARI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • Looking at the Operating Margin, with a value of 4.79%, CLARI is in line with its industry, outperforming 57.58% of the companies in the same industry.
  • CLARI's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CLARI (91.90%) is better than 93.94% of its industry peers.
  • CLARI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.79%
PM (TTM) N/A
GM 91.9%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
CLARI.PA Yearly Profit, Operating, Gross MarginsCLARI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLARI is destroying value.
  • CLARI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLARI has been increased compared to 5 years ago.
  • CLARI has a better debt/assets ratio than last year.
CLARI.PA Yearly Shares OutstandingCLARI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLARI.PA Yearly Total Debt VS Total AssetsCLARI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.62, we must say that CLARI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.62, CLARI is doing worse than 72.73% of the companies in the same industry.
  • The Debt to FCF ratio of CLARI is 13.25, which is on the high side as it means it would take CLARI, 13.25 years of fcf income to pay off all of its debts.
  • CLARI's Debt to FCF ratio of 13.25 is in line compared to the rest of the industry. CLARI outperforms 42.42% of its industry peers.
  • A Debt/Equity ratio of 1.90 is on the high side and indicates that CLARI has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.90, CLARI is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Altman-Z 0.62
ROIC/WACC0.38
WACC4.24%
CLARI.PA Yearly LT Debt VS Equity VS FCFCLARI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
  • CLARI has a worse Current ratio (0.67) than 63.64% of its industry peers.
  • A Quick Ratio of 0.65 indicates that CLARI may have some problems paying its short term obligations.
  • CLARI has a Quick ratio of 0.65. This is comparable to the rest of the industry: CLARI outperforms 48.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.65
CLARI.PA Yearly Current Assets VS Current LiabilitesCLARI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.92%, which is quite impressive.
  • The Revenue has been growing slightly by 2.70% in the past year.
  • Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%

3.2 Future

  • CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.80% yearly.
  • CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.96% yearly.
EPS Next Y80.02%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLARI.PA Yearly Revenue VS EstimatesCLARI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
CLARI.PA Yearly EPS VS EstimatesCLARI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 14.81, CLARI is valued correctly.
  • CLARI's Price/Forward Earnings ratio is in line with the industry average.
  • CLARI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE N/A
Fwd PE 14.81
CLARI.PA Price Earnings VS Forward Price EarningsCLARI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • 63.64% of the companies in the same industry are more expensive than CLARI, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLARI indicates a rather cheap valuation: CLARI is cheaper than 93.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.22
EV/EBITDA 8.44
CLARI.PA Per share dataCLARI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • CLARI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CLARI's earnings are expected to grow with 53.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.89%
EPS Next 3Y53.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
  • CLARI's Dividend Yield is rather good when compared to the industry average which is at 1.61. CLARI pays more dividend than 100.00% of the companies in the same industry.
  • CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

  • The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
CLARI.PA Yearly Dividends per shareCLARI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.94%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
CLARI.PA Yearly Income VS Free CF VS DividendCLARI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

CLARIANE SE

EPA:CLARI (2/6/2026, 7:00:00 PM)

3.838

-0.07 (-1.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27
Earnings (Next)02-26
Inst Owners45.31%
Inst Owner ChangeN/A
Ins Owners5.61%
Ins Owner ChangeN/A
Market Cap1.37B
Revenue(TTM)5.31B
Net Income(TTM)-61.38M
Analysts77.14
Price Target4.51 (17.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.37%
PT rev (3m)-5.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-165.52%
EPS NY rev (3m)-154.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.81
P/S 0.26
P/FCF 2.22
P/OCF 1.55
P/B 0.38
P/tB N/A
EV/EBITDA 8.44
EPS(TTM)-0.16
EYN/A
EPS(NY)0.26
Fwd EY6.75%
FCF(TTM)1.73
FCFY45.11%
OCF(TTM)2.47
OCFY64.47%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROCE 2.21%
ROIC 1.62%
ROICexc 1.74%
ROICexgc 3.52%
OM 4.79%
PM (TTM) N/A
GM 91.9%
FCFM 11.63%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Debt/EBITDA 6.54
Cap/Depr 33.65%
Cap/Sales 4.99%
Interest Coverage 0.83
Cash Conversion 84.73%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.65
Altman-Z 0.62
F-Score6
WACC4.24%
ROIC/WACC0.38
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y80.02%
EPS Next 2Y74.89%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%
EBIT growth 1Y-22.4%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year283.2%
EBIT Next 3Y64.52%
EBIT Next 5Y37.45%
FCF growth 1Y267.45%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%

CLARIANE SE / CLARI.PA FAQ

What is the fundamental rating for CLARI stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLARI.PA.


Can you provide the valuation status for CLARIANE SE?

ChartMill assigns a valuation rating of 5 / 10 to CLARIANE SE (CLARI.PA). This can be considered as Fairly Valued.


What is the profitability of CLARI stock?

CLARIANE SE (CLARI.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CLARI stock?

The dividend rating of CLARIANE SE (CLARI.PA) is 5 / 10 and the dividend payout ratio is -110.94%.